310 related articles for article (PubMed ID: 15975010)
1. Adeno-associated virus (AAV) vectors in the CNS.
McCown TJ
Curr Gene Ther; 2005 Jun; 5(3):333-8. PubMed ID: 15975010
[TBL] [Abstract][Full Text] [Related]
2. Adeno-Associated Virus (AAV) Vectors in the CNS.
McCown TJ
Curr Gene Ther; 2011 Jun; 11(3):181-8. PubMed ID: 21453285
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vectors and neurological gene therapy.
Ojala DS; Amara DP; Schaffer DV
Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
[TBL] [Abstract][Full Text] [Related]
4. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
[TBL] [Abstract][Full Text] [Related]
5. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
6. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
7. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
Grimm D; Kay MA
Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
Saraiva J; Nobre RJ; Pereira de Almeida L
J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
[TBL] [Abstract][Full Text] [Related]
9. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
10. The state of the art of adeno-associated virus-based vectors in gene therapy.
Coura Rdos S; Nardi NB
Virol J; 2007 Oct; 4():99. PubMed ID: 17939872
[TBL] [Abstract][Full Text] [Related]
11. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
[TBL] [Abstract][Full Text] [Related]
12. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.
Blessing D; Déglon N
Curr Opin Virol; 2016 Dec; 21():61-66. PubMed ID: 27559630
[TBL] [Abstract][Full Text] [Related]
14. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy and neurodevelopmental disorders.
Gray SJ
Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity.
Haberman R; Criswell H; Snowdy S; Ming Z; Breese G; Samulski R; McCown T
Mol Ther; 2002 Oct; 6(4):495-500. PubMed ID: 12377191
[TBL] [Abstract][Full Text] [Related]
17. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
18. AAV vector delivery to cells in culture.
Smith A; Collaco R; Trempe JP
Methods Mol Biol; 2004; 246():167-77. PubMed ID: 14970591
[TBL] [Abstract][Full Text] [Related]
19. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
Liu Y; Siriwon N; Rohrs JA; Wang P
Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus vectors: activity and applications in the CNS.
Peel AL; Klein RL
J Neurosci Methods; 2000 Jun; 98(2):95-104. PubMed ID: 10880823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
